Symptom Burden and Immune Dynamics 6 to 18 Months Following Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2): A Case-control Study

por Fjelltveit, Elisabeth B, Blomberg, Bjørn, Kuwelker, Kanika, Zhou, Fan, Onyango, Therese B, Brokstad, Karl A, Elyanow, Rebecca, Kaplan, Ian M, Tøndel, Camilla, Mohn, Kristin G I, Özgümüş, Türküler, Cox, Rebecca J, Langeland, Nina
Publicado 2022

Durable T-cellular and humoral responses in SARS-CoV-2 hospitalized and community patients

por Mohn, Kristin G.-I., Bredholt, Geir, Zhou, Fan, Madsen, Anders, Onyango, Therese B., Fjelltveit, Elisabeth B., Jalloh, Sarah L., Brokstad, Karl A., Cantoni, Diego, Mayora-Neto, Martin, Temperton, Nigel, Langeland, Nina, Cox, Rebecca J.
Publicado 2022